RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 104 participants.
Also called NCT07889388
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 104 participants
- Sponsor
- Bionime Corporation
- Registry
-
NCT07889388
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT07889388. Allocation not applicable; no masking; primary purpose other. Start 2026-06-09 (actual); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
- Condition
- Diabetes Mellitus, Type 1 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Diabetes, Gestational
- Intervention (Device)
- RIGHTEST iFree 2 Continuous Glucose Monitoring System
- Lead sponsor
- Bionime Corporation
Record details
- Record id
cardio:ct-nct07889388- Content hash
c1e06ad3ae3538fba1ee8da16c5e334fd0700d0c5bdca4b913635fa7762877a5